CompaniesInterferon Source

Interferon Source

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

105

By Phase

NA: 2

By Status

COMPLETED: 2

Clinical Trials Pipeline

No trials with date information available

Recent Trials

NCT00002012Lead Sponsor

Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients

45 participants

NCT00002018Lead Sponsor

Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects

60 participants